GFC Life Science Co., Ltd (KOSDAQ:388610)
10,330
+250 (2.48%)
At close: Mar 20, 2026
-21.68% (1Y)
| Market Cap | 54.37B -11.7% |
| Revenue (ttm) | 13.74B +91.8% |
| Net Income | 1.62B |
| EPS | 1,560.00 |
| Shares Out | 5.26M |
| PE Ratio | 6.52 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,309 |
| Average Volume | 53,721 |
| Open | 10,090 |
| Previous Close | 10,080 |
| Day's Range | 10,080 - 10,450 |
| 52-Week Range | 9,360 - 40,000 |
| Beta | 1.13 |
| RSI | 39.89 |
| Earnings Date | Mar 25, 2026 |